Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 41 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Tumor Markers, Biological  [Clear All Filters]
2014
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Dedemadi G., Goumas C., et al. (2014).  The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer.. Tumour Biol. 35(6), 5993-6002.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Pectasides, E., Rampias T., Sasaki C., Perisanidis C., Kouloulias V., Burtness B., et al. (2014).  Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).. PLoS One. 9(4), e94273.
Psyrri, A., Lee J-W., Pectasides E., Vassilakopoulou M., Kosmidis E. K., Burtness B. A., et al. (2014).  Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.. Clin Cancer Res. 20(11), 3023-32.
Pentheroudakis, G., Kotoula V., Fountzilas E., Kouvatseas G., Basdanis G., Xanthakis I., et al. (2014).  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).. BMC Cancer. 14, 111.
2013
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Briasoulis, E., Aravantinos G., Kouvatseas G., Pappas P., Biziota E., Sainis I., et al. (2013).  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.. BMC Cancer. 13, 263.
Batistatou, A., Televantou D., Bobos M., Eleftheraki A. G., Kouvaras E., Chrisafi S., et al. (2013).  Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.. Anticancer Res. 33(5), 2139-45.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Moulla, A., Miliaras D., Sioga A., Kaidoglou A., & Economou L. (2013).  The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.. Pol J Pathol. 64(3), 180-4.
Mountzios, G., Kostopoulos I., Kotoula V., Sfakianaki I., Fountzilas E., Markou K., et al. (2013).  Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.. PLoS One. 8(1), e54048.
Rampias, T., Pectasides E., Prasad M., Sasaki C., Gouveris P., Dimou A., et al. (2013).  Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.. Ann Oncol. 24(8), 2124-31.
Bojesen, S. E., Pooley K. A., Johnatty S. E., Beesley J., Michailidou K., Tyrer J. P., et al. (2013).  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nat Genet. 45(4), 371-84, 384e1-2.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.
Pentheroudakis, G., Kotoula V., Eleftheraki A. G., Tsolaki E., Wirtz R. M., Kalogeras K. T., et al. (2013).  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).. PLoS One. 8(7), e70634.
de Sanjose, S., Alemany L., Ordi J., Tous S., Alejo M., Bigby S. M., et al. (2013).  Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.. Eur J Cancer. 49(16), 3450-61.
2012
Kaiafa, G. D., Perifanis V., Diamantidis M. D., Giouleme O., Voulgaridou V., Beretouli E., et al. (2012).  Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma.. Ann Hematol. 91(7), 1157-9.
Kaiafa, G. D., Saouli Z., Diamantidis M. D., Kontoninas Z., Voulgaridou V., Raptaki M., et al. (2012).  Copper levels in patients with hematological malignancies.. Eur J Intern Med. 23(8), 738-41.
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Kotoula, V., Krikelis D., Karavasilis V., Koletsa T., Eleftheraki A. G., Televantou D., et al. (2012).  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).. BMC Cancer. 12, 342.
Zarogoulidis, K., Eleftheriadou E., Kontakiotis T., Gerasimou G., Zarogoulidis P., Sapardanis I., et al. (2012).  Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.. Lung Cancer. 76(1), 84-8.
Masoura, S., Kourtis A., Kalogiannidis I., Kotoula V., Anagnostou E., Angelidou S., et al. (2012).  Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a 23-year-old woman: A case report.. Pathol Res Pract. 208(4), 245-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.